Stock Events

Stock Events

MiNK Therapeutics (INKT) Q2 2026 Earnings

May 15Confirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-1.06

-0.89

-0.72

-0.55

Details

Expected EPS

-0.77

Actual EPS

-0.57

Surprise EPS

0.2

Surprise Percent

+25.97%

Description

⁨MiNK Therapeutics⁩ (⁦INKT⁩) has reported earnings of ⁦-0.57⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.